The histone demethylase LSD1 is required for estrogen-dependent S100A7 gene expression in human breast cancer cells

Biochemical and Biophysical Research Communications

Volumn 427, Issue 2, 2012, Pages 336-342

  Yu, Seung Eun ^a   Jang, Yeun Kyu ^a  

^a Yonsei University   (South Korea)

Author keywords

Breast cancer cells; Estrogen mediated transcriptional regulation; Histone demethylase LSD1; S100A7

Indexed keywords

ENZYME INHIBITOR; ESTRADIOL; HISTONE DEMETHYLASE; HISTONE DEMETHYLASE LSD1 INHIBITOR; LSD1 ENZYME; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL; CONTROLLED STUDY; ENZYME ACTIVITY; GENE; GENE ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; S100A7 GENE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEMETHYLASES; HUMANS; PROMOTER REGIONS, GENETIC; S100 PROTEINS;

EID: 84867858271     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.09.057     Document Type: Article

References (25)

1. Schäfer B.W., Heizmann C.W. The S100 family of EF-hand calcium-binding proteins: functions and pathology. Trends Biochem. Sci. 1996, 21:134-140.
2. Paruchuri V., Prasad A., McHugh K., Bhat H.K., Polyak K., Ganju R.K. S100A7-downregulation inhibits epidermal growth factor-induced signaling in breast cancer cells and blocks osteoclast formation. PloS one 2008, 3:e1741.
3. Morgan M.R., Jazayeri M., Ramsay A.G., Thomas G.J., Boulanger M.J., Hart I.R., Marshall J.F. Psoriasin (S100A7) associates with integrin beta6 subunit and is required for alphavbeta6-dependent carcinoma cell invasion. Oncogene 2011, 30:1422-1435.
4. Shubbar E., Vegfors J., Carlstrom M., Petersson S., Enerback C. Psoriasin (S100A7) increases the expression of ROS and VEGF and acts through RAGE to promote endothelial cell proliferation. Breast Cancer Res. Treat. 2012, 134:71-80.
5. Al-Haddad S., Zhang Z., Leygue E., Snell L., Huang A., Niu Y., Hiller-Hitchcock T., Hole K., Murphy L.C., Watson P.H. Psoriasin (S100A7) expression and invasive breast cancer. Am. J. Pathol. 1999, 155:2057-2066.
6. Alowami S., Qing G., Emberley E., Snell L., Watson P. Psoriasin (S100A7) expression is altered during skin tumorigenesis. BMC Dermatology 2003, 3:1.
7. Celis J.E., Rasmussen H.H., Vorum H., Madsen P., Honore B., Wolf H., Orntoft T.F. Bladder squamous cell carcinomas express psoriasin and externalize it to the urine. J. Urol. 1996, 155:2105.
8. Emberley E.D., Niu Y., Njue C., Kliewer E.V., Murphy L.C., Watson P.H. Psoriasin (S100A7) expression is associated with poor outcome in estrogen receptor-negative invasive breast cancer. Clin. cancer res. 2003, 9:2627-2631.
9. Krop I., Marz A., Carlsson H., Li X., Bloushtain-Qimron N., Hu M., Gelman R., Sabel M.S., Schnitt S., Ramaswamy S., Kleer C.G., Enerback C., Polyak K. A putative role for psoriasin in breast tumor progression. Cancer Res. 2005, 65:11326-11334.
10. Emberley E.D., Niu Y., Leygue E., Tomes L., Gietz R.D., Murphy L.C., Watson P.H. Psoriasin interacts with Jab1 and influences breast cancer progression. Cancer Res. 2003, 63:1954.
11. Deol Y.S., Nasser M.W., Yu L., Zou X., Ganju R.K. Tumor-suppressive effects of psoriasin (S100A7) are mediated through the beta-catenin/T cell factor 4 protein pathway in estrogen receptor-positive breast cancer cells. J. Biol. Chem. 2011, 286:44845-44854.
12. West N., Watson P. S100A7 (psoriasin) is induced by the proinflammatory cytokines oncostatin-M and interleukin-6 in human breast cancer. Oncogene 2010, 29:2083-2092.
13. Skliris G.P., Lewis A., Emberley E., Peng B., Weebadda W.K., Kemp A., Davie J.R., Shiu R.P., Watson P.H., Murphy L.C. Estrogen receptor-beta regulates psoriasin (S100A7) in human breast cancer. Breast Cancer Res. Treat. 2007, 104:75-85.
14. Hall J.M., Couse J.F., Korach K.S. The multifaceted mechanisms of estradiol and estrogen receptor signaling. J. Biol. Chem. 2001, 276:36869-36872.
15. Yu S.E., Park S.H., Jang Y.K. Epigenetic silencing of TNFSF7 (CD70) by DNA methylation during progression to breast cancer. Mol. Cells 2010, 29:217-221.
16. Perillo B., Ombra M.N., Bertoni A., Cuozzo C., Sacchetti S., Sasso A., Chiariotti L., Malorni A., Abbondanza C., Avvedimento E.V. DNA oxidation as triggered by H3K9me2 demethylation drives estrogen-induced gene expression. Science 2008, 319:202-206.
17. Metzger E., Wissmann M., Yin N., Muller J.M., Schneider R., Peters A.H., Gunther T., Buettner R., Schule R. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature 2005, 437:436-439.
18. Stavropoulos P., Blobel G., Hoelz A. Crystal structure and mechanism of human lysine-specific demethylase-1. Nat. Struct. Mol. Biol. 2006, 13:626-632.
19. Dees C., Askari M., Foster J.S., Ahamed S., Wimalasena J. DDT mimicks estradiol stimulation of breast cancer cells to enter the cell cycle. Mol. Carcinogen. 1997, 18:107-114.
20. Garcia-Bassets I., Kwon Y.S., Telese F., Prefontaine G.G., Hutt K.R., Cheng C.S., Ju B.G., Ohgi K.A., Wang J., Escoubet-Lozach L., Rose D.W., Glass C.K., Fu X.D., Rosenfeld M.G. Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors. Cell 2007, 128:505-518.
21. Webb M., Emberley E.D., Lizardo M., Alowami S., Qing G., Alfia'ar A., Snell-Curtis1 L.J., Niu1 Y., Civetta A., Myal Y., Shiu1 R., Murphy1 L.C., Watson P.H. Expression analysis of the mouse S100A7/psoriasin gene in skin inflammation and mammary tumorigenesis. BMC Cancer 2005, 5:17.
22. Wissmann M., Yin N., Muller J.M., Greschik H., Fodor B.D., Jenuwein T., Vogler C., Schneider R., Gunther T., Buettner R., Metzger E., Schule R. Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression. Nat. Cell Biol. 2007, 9:347-353.
23. Gao H., Bryzgalova G., Hedman E., Khan A., Efendic S., Gustafsson J.A., Dahlman-Wright K. Long-term administration of estradiol decreases expression of hepatic lipogenic genes and improves insulin sensitivity in ob/ob mice. a possible mechanism is through direct regulation of signal transducer and activator of transcription 3. Mol. Endocrinol. 2006, 20:1287-1299.
24. Yang J., Huang J., Dasgupta M., Sears N., Miyagi M., Wang B., Chance M.R., Chen X., Du Y., Wang Y., An L., Wang Q., Lu T., Zhang X., Wang Z., Stark G.R. Reversible methylation of promoter-bound STAT3 by histone-modifying enzymes. Proc. Natl. Acad. Sci. USA 2010, 107:21499-21504.
25. Frasor J., Danes J.M., Komm B., Chang K.C., Lyttle C.R., Katzenellenbogen B.S. Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 2003, 144:4562-4574.